The Wire · All news

PFAS in Water: What to Check

Judge Gergel (D.S.C., AFFF MDL-2873) granted final approval of 3M's public water supplier settlement: $10.3B pre-tax present value, up to $12.5B nominal, paid over 13 years starting Q3 2024, covering U.S. public water suppliers that have detected or may detect PFAS.

Published Updated

By People's Justice

What happened

Judge Gergel (D.S.C., AFFF MDL-2873) granted final approval of 3M's public water supplier settlement: $10.3B pre-tax present value, up to $12.5B nominal, paid over 13 years starting Q3 2024, covering U.S. public water suppliers that have detected or may detect PFAS. Verified via 3M's official press release.

Event date:

Source: investors.3m.com

Related news

  1. PFAS in Water: What to Check

    Chemours, DuPont and Corteva announced a $1.185B settlement fund resolving PFAS drinking-water claims of a defined class of U.S. public water systems (Chemours ~$592M, DuPont ~$400M, Corteva ~$193M), subject to D.S.C. court approval in AFFF MDL-2873; excludes state/federally owned systems and most lower Cape Fear Basin systems.

    Chemours, DuPont and Corteva announced a $1.185B settlement fund resolving PFAS drinking-water claims of a defined class of U.S. public water systems (Chemours ~$592M, DuPont ~$400M, Corteva ~$193M), subject to D.S.C. court approval in AFFF MDL-2873; excludes state/federally owned systems and most lower Cape Fear Basin systems. Verified via DuPont's official press release. (Final court approval followed in Feb 2024 per SEC filings — approval date not independently fetched.)

    Source: dupont.com

  2. PFAS in Water: What to Check

    Personal-injury track status: by Case Management Order No. 35 (Aug. 15, 2025), Judge Richard M. Gergel vacated the bellwether trial set for October 20, 2025, and all related dates in CMO 26-I, citing a large number of unfiled cases, and opened a 21-day Filing Facilitation Window for personal-injury cases alleging one of the six listed injuries (kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer and thyroid cancer).

    Personal-injury track status: by Case Management Order No. 35 (Aug. 15, 2025), Judge Richard M. Gergel vacated the bellwether trial set for October 20, 2025, and all related dates in CMO 26-I, citing a large number of unfiled cases, and opened a 21-day Filing Facilitation Window for personal-injury cases alleging one of the six listed injuries (kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer and thyroid cancer). The JPML reported 15,264 actions pending in MDL 2873 on October 1, 2026; that count covers all actions in the MDL.

    Source: scd.uscourts.gov

  3. PFAS in Water: What to Check